Aligos Therapeutics, Inc. 10-Q filing
Filed 2025-11-06 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001193125-25-268203
- Form type
- 10-Q
- CIK
- 0001799448
- Primary document
- https://www.sec.gov/Archives/edgar/data/1799448/000119312525268203/algs-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aligos Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $2.0M | - | - |
| Operating Income | $-66.2M | - | - |
| Net Income | $-4.3M | - | - |
| Eps Basic | -0.44 | - | - |
| Eps Diluted | -0.44 | - | - |
| Cash And Equivalents | $41.9M | - | - |
| Total Assets | $109.8M | - | - |
| Total Liabilities | $37.9M | - | - |
| Shareholders Equity | $71.8M | - | - |
| Operating Cash Flow | $-60.8M | - | - |